Muscle Relaxer Dosing for Acute Low Back Pain
Skeletal muscle relaxants should be used for short-term relief (2-4 days) in acute low back pain, but the evidence shows they provide only modest benefit over placebo with significant sedation risk, and no specific muscle relaxant has proven superior to others. 1
Key Recommendation
The American College of Physicians/American Pain Society guidelines establish that muscle relaxants are an option for short-term relief of acute low back pain, but all are associated with central nervous system adverse effects, primarily sedation 1. Importantly, there is no compelling evidence that skeletal muscle relaxants differ in efficacy or safety 1.
Evidence Quality and Limitations
While older Cochrane reviews from 2003 suggested "strong evidence" for muscle relaxant efficacy 2, 3, more recent high-quality evidence challenges this:
- A 2022 emergency department study found no statistically significant difference between any muscle relaxant and placebo when combined with NSAIDs 4
- A 2026 systematic review using the REB method found none of the commonly used muscle relaxants (thiocolchicoside, methocarbamol, diazepam) demonstrated efficacy for acute low back pain 5
The pooled data from older trials showed only modest benefit: relative risk of 0.80 for pain relief after 2-4 days, but with significantly more adverse events (RR 1.50), especially CNS effects like sedation (RR 2.04) 2, 3.
Practical Approach
First-Line Treatment
Start with acetaminophen or NSAIDs as first-line agents 1. These should be the foundation of pharmacologic management.
When to Consider Muscle Relaxants
Add a muscle relaxant only if:
- Pain is severe and not controlled with first-line agents
- Patient can tolerate sedation
- Short-term use only (days, not weeks)
Specific Agent Selection
No specific muscle relaxant is recommended over another based on efficacy 1. Selection should be based on:
- Avoid carisoprodol: metabolized to meprobamate with abuse potential 1
- Avoid dantrolene: black box warning for potentially fatal hepatotoxicity 1
- Use caution with tizanidine and chlorzoxazone: associated with generally reversible hepatotoxicity 1
- Cyclobenzaprine: most studied but highest adverse event rate in recent trials 4
Duration
Time-limited course only - typically 2-4 days maximum 1, 2, 3. Extended use is not supported by evidence and increases risk of adverse effects.
Critical Caveats
Benzodiazepines should not be routinely used despite similar efficacy to muscle relaxants, due to risks of abuse, addiction, and tolerance 1. If used, strictly time-limited course 1.
All muscle relaxants cause significant sedation - warn patients about driving, operating machinery, and combining with alcohol or other CNS depressants 1, 2, 3.
The evidence base is weak: Most trials showing benefit are older, and the most recent high-quality evidence suggests muscle relaxants may not be more effective than placebo when combined with NSAIDs 4, 5.
Bottom Line Algorithm
- Start: Acetaminophen or NSAIDs + patient education to stay active
- If inadequate relief: Add short-term muscle relaxant (2-4 days maximum)
- Choose any non-carisoprodol, non-dantrolene agent based on availability and cost
- Warn about sedation and CNS effects
- Reassess in 2-4 days - if no improvement, discontinue and consider alternative approaches rather than continuing muscle relaxants
The guidelines emphasize that staying active is more important than medication for acute low back pain 1, and muscle relaxants should be viewed as a short-term adjunct, not a primary treatment strategy.